Not Yet RecruitingNot Applicable

The Caribbean Registry of Extracorporeal Membrane Oxygenation (ECMO) From the University Hospital in Martinique

1,200 participantsStarted 2026-02-01

Plain-language summary

The project's main goal is to collect baseline clinical and procedural data as well as to assess clinical outcomes for all patients undergoing VV, VA or VAV ECMO implantation in the French West Indies and Guiana. All patients undergoing ECMO implantation will be prospectively registered.

Who can participate

Age range90 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * All consecutive patients implanted with a veno-venous extracorporeal membrane oxygenation device or extracorporeal membrane oxygenation device by the HeartTeam from the University Hospital of Martinique (UHM) from January 2010 Exclusion Criteria: * Patients with incomplete data (primary endpoint and less than 80% secondary study outcomes)

What they're measuring

Mortality at 30 days

Timeframe: from canula implantation to 30 days afterwards

Trial details

NCT IDNCT07351435

SponsorUniversity of Genova

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2032-12-31

Contact for this trial

Marc LICKER, MD

+41796234488 marc.licker@unige.ch

View on ClinicalTrials.gov More Cardiogenic Shock trials